Cornea/External Disease News

Aldeyra Therapeutics has resubmitted a new drug application for topical reproxalap for the treatment of signs and symptoms of dry eye disease, the company announced in a press release.

BARCELONA, Spain — In this Healio Video Perspective from the European Society of Cataract and Refractive Surgeons meeting, Soosan Jacob, MS, FRCS, DNB, discusses custom-shaped CAIRS for the treatment of keratoconus.

Thermal cooling rate and noninvasive tear breakup time significantly predicted contact lens-induced dry eye, according to a study published in Optometry and Vision Science.

The corneal nerve parameters of patients with multiple sclerosis could be used to evaluate and monitor the stages of the disease, according to a poster presented at the Women in Ophthalmology Summer Symposium.

Concurrent use of a beta-blocker with Simbrinza delayed the onset of ocular allergy and may extend treatment duration and adherence among patients with glaucoma, according to a retrospective study in BMC Ophthalmology.

BARCELONA, Spain — In this Healio Video Perspective from the European Society of Cataract and Refractive Surgeons meeting, Amar Agarwal, MS, FRCS, FRCOphth, shares his experience with pinhole pupilloplasty.

BARCELONA, Spain — In this Healio Video Perspective, Emilio Torres-Netto, MD, PhD, shares his experience with selective treatment of astigmatism in radial keratotomy, or STARK, a new application of corneal cross-linking.

Dry eye disease is common in glaucoma patients treated with hypotonizing eye drops, with 56.1% of patients reporting subjective signs of dry eye, according to a study in the Open Journal of Ophthalmology.

The FDA and Palatin Technologies have agreed on protocols and sign and symptom endpoints for the remaining phase 3 clinical trials of PL9643 for dry eye disease, the company announced in a press release.

BARCELONA, Spain — In this Healio Video Perspective from the European Society of Cataract and Refractive Surgeons meeting, Alan R. Faulkner, MD, shares his experience with the Ally system from Lensar for femtosecond cataract surgery.